G
Ghayas C Issa
Researcher at Harvard University
Publications - 110
Citations - 3071
Ghayas C Issa is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 11 publications receiving 2325 citations. Previous affiliations of Ghayas C Issa include University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients with Acute Myeloid Leukemia: Analysis of Outcomes and Contemporary Trends Spanning 10 Years
Alexandre Bazinet,Hagop M. Kantarjian,Naszrin Arani,Uday R. Popat,Courtney D. DiNardo,Naval Daver,Musa Yilmaz,Hussein A. Abbas,Nicholas J. Short,Ghayas C Issa,Elias Jabbour,Sherry Pierce,Julianne Chen,Ricky Garcia,Marina Konopleva,Guillermo Garcia-Manero,Amin M. Alousi,Elizabeth J. Shpall,Richard E. Champlin,Gautam Borthakur,Farhad Ravandi,Tapan M. Kadia +21 more
TL;DR: In this article , the authors conducted a retrospective study spanning 10 years to evaluate SCT-related outcomes in older patients with acute myeloid leukemia (AML) presenting to their institution with newly-diagnosed (ND) AML.
Journal ArticleDOI
A Suboptimal Response in CML Is Associated with Expression of the Immune Checkpoint VISTA
Aram H Bidikian,Sreyashi Basu,He Zhong,Himachandana Atluri,Jabra Zarka,Michael Andreeff,Koji Sasaki,Elias Jabbour,Jorge E. Cortes,Padmanee Sharma,Ghayas C Issa +10 more
TL;DR: In this article , a comparison of immune determinants of response in CML in those who achieve a deep molecular response (MR4.5) compared to suboptimal responders is presented.
Journal ArticleDOI
Somatic Mutations in TP53 Identified in T-Cells of Patients with TP53-mutated AML
Ghayas C Issa,Aram H Bidikian,Edward Ayoub,Feng Wang,Vakul Mohanty,Jake S. Leighton,Xiaogang Wu,Tallie Patsilevas,Zoe Alaniz,Jabra Zarka,Rashmi Kanagal-Shamanna,Naval Daver,Andrew Futreal,Marina Konopleva,Nicholas Navin,Jian Zhang,Kenneth S. Chen,Michael Andreeff +17 more
TL;DR: Bentham et al. as mentioned in this paper used whole exome sequencing (WES) to identify mutations in pre-malignant cell populations characterized as clonal hematopoiesis (CH).
Journal ArticleDOI
Poster: CML-288 Impact of ASXL1 Mutations on Prognosis of Chronic Phase Chronic Myeloid Leukemia
Aram H Bidikian,Hagop M. Kantarjian,Elias Jabbour,Nicholas J. Short,Farhad Ravandi,Ghayas C Issa,Koji Sasaki +6 more
Journal ArticleDOI
Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring
Alex Bataller,F. Haddad,Ghayas C Issa,Koji Sasaki,Elias Jabbour,Gautam Borthakur,Alessandra Ferrajoli,Nicholas J. Short +7 more
TL;DR: Myeloid leukemia (myeloid leukemia) as mentioned in this paper ) is a type of cancer that occurs in humans, and it can be treated with immunotherapy, chemotherapy, and radiotherapy.